These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15188385)

  • 1. Intraarticular injection of anti-tumor necrosis factor: Comment on the letter by Arnold et al.
    Bliddal H
    Arthritis Rheum; 2004 Jun; 50(6):2037-8. PubMed ID: 15188385
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute injection site reaction to intraarticular etanercept administration.
    Arnold EL; Khanna D; Paulus H; Goodman MP
    Arthritis Rheum; 2003 Jul; 48(7):2078-9. PubMed ID: 12847708
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
    Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
    Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic sarcoid arthritis treated with intraarticular etanercept.
    Hobbs K
    Arthritis Rheum; 2005 Mar; 52(3):987-8. PubMed ID: 15751067
    [No Abstract]   [Full Text] [Related]  

  • 5. Should we be using intraarticular tumor necrosis factor blockade in inflammatory monoarthritis?
    Fisher BA; Keat A
    J Rheumatol; 2006 Oct; 33(10):1934-5. PubMed ID: 17014012
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.
    Bliddal H; Terslev L; Qvistgaard E; Konig M; Holm CC; Rogind H; Boesen M; Danneskiold-Samsøe B; Torp-Pedersen S
    Scand J Rheumatol; 2006; 35(5):341-5. PubMed ID: 17062431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing antitumor necrosis factor drugs to patients with heart failure.
    Ziegelstein RC
    Arch Intern Med; 2005 Jan; 165(1):118-9. PubMed ID: 15642887
    [No Abstract]   [Full Text] [Related]  

  • 8. Etanercept ameliorates sarcoidosis arthritis and skin disease.
    Khanna D; Liebling MR; Louie JS
    J Rheumatol; 2003 Aug; 30(8):1864-7. PubMed ID: 12913948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis induced by anti-tumor necrosis factor therapy: a class effect?
    Richette P; Viguier M; Bachelez H; Bardin T
    J Rheumatol; 2007 Feb; 34(2):438-9. PubMed ID: 17304662
    [No Abstract]   [Full Text] [Related]  

  • 10. Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis.
    Koens L; Senff NJ; Vermeer MH; Ronday HK; Willemze R; Jansen PM
    Acta Derm Venereol; 2009 Nov; 89(6):653-4. PubMed ID: 19997706
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of eczematous and vesicular dermatitis during anti-TNFalpha therapy for rheumatoid arthritis.
    Savoia F; Gaddoni G; Casadio C; Spadola G; Patrizi A; Giacomini F; Aldi M
    G Ital Dermatol Venereol; 2011 Aug; 146(4):308-9. PubMed ID: 21785399
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of relapsing polychondritis with a TNF antagonist.
    Carter JD
    J Rheumatol; 2005 Jul; 32(7):1413. PubMed ID: 15996093
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of pseudogout during etanercept treatment.
    Josefina M; Ana CJ; Ariel V; Silvio AA
    J Clin Rheumatol; 2007 Jun; 13(3):177. PubMed ID: 17551392
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society].
    Salvarani C; Olivieri I; Cantini F; Marchesoni A; Punzi L; Scarpa R; Matucci-Cerinic M
    Reumatismo; 2004; 56(3):133-4, 136-8. PubMed ID: 15470517
    [No Abstract]   [Full Text] [Related]  

  • 15. Transient and slight thrombocytopaenia induced by etanercept during treatment of psoriatic arthritis.
    Stinco G; Piccirillo F; Patrone P
    Acta Derm Venereol; 2008; 88(3):281-2. PubMed ID: 18480934
    [No Abstract]   [Full Text] [Related]  

  • 16. Results from an open-label extension study of etanercept in ankylosing spondylitis.
    Davis J; Webb A; Lund S; Sack K
    Arthritis Rheum; 2004 Apr; 51(2):302-4. PubMed ID: 15077279
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
    Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data.
    Delaunay C; Farrenq V; Marini-Portugal A; Cohen JD; Chevalier X; Claudepierre P
    J Rheumatol; 2005 Nov; 32(11):2183-5. PubMed ID: 16265699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine history knowledge of subcutaneous anti-TNF receiving rheumatology patients.
    Nolan TJ; O'Connor MB; Bond U; Swan J; Phelan MJ
    Rheumatol Int; 2013 Jul; 33(7):1907-8. PubMed ID: 22441967
    [No Abstract]   [Full Text] [Related]  

  • 20. Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor alpha-blocking agent: comment on the article by Pisetsky and the letter from Aringer et al.
    Fautrel B; Foltz V; Frances C; Bourgeois P; Rozenberg S
    Arthritis Rheum; 2002 May; 46(5):1408-9; author reply 1409. PubMed ID: 12115253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.